# FDA recall D-0891-2023

> **SUN PHARMACEUTICAL INDUSTRIES INC** · Class II · drug recall initiated 2023-05-30.

## Product

Amphotericin B Liposome for Injection, 50mg/vial, Rx only, Distributed by Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by Sun Pharmaceutical Medicare Limited, Baska Ujeti Road, Ujeti, Halol-389350, Gujarat, India, NDC 62756-0233-01

## Reason for recall

Subpotent drug

## Distribution

USA nationwide

## Key facts

- **Recall number:** D-0891-2023
- **Recalling firm:** SUN PHARMACEUTICAL INDUSTRIES INC
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2023-05-30
- **Report date:** 2023-07-05
- **Termination date:** 2023-12-18

- **Voluntary/Mandated:** N/A
- **Location:** Princeton, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0891-2023

## Citation

> AI Analytics. FDA recall D-0891-2023. Retrieved 2026-06-09 from https://api.ai-analytics.org/recall/D-0891-2023. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*